<DOC>
	<DOCNO>NCT00585299</DOCNO>
	<brief_summary>To assess whether reversal fatty liver moderate weight loss ( 8 % body weight ) lead improvement insulin sensitivity , associate change glucose status lipid profile , obese child adolescent fatty liver normal glucose pre-diabetes .</brief_summary>
	<brief_title>Effects Weight Loss Hepatic Muscle Lipid Content Insulin Sensitivity Obese Adolescents With NAFLD</brief_title>
	<detailed_description>This study two group : one group eat moderate calorie , low-fat diet weigh regularly ( every week 16 week ) receive traditional diet therapy return 16 week . Both group undergo procedure test glucose tolerance measure liver muscle fat content study period .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>10 21 yr age Nonsmoking BMI &gt; 95th percentile age gender , BMI &lt; 40 Suspicion fatty liver , high ALT ( &gt; 35 ) Normal glucose tolerance prediabetes ( impaired glucose tolerance impair fast glucose ) Females childbearing potential use birth control Pregnant lactating female Current medication except oral antidiabetic medication hormonal birth control Lipidlowering medication increase liver enzymes Significant kidney dysfunction ( creatinine &gt; 1.5 mg/dL ) Current heavy ethanol use recent history binge drink History evidence hepatitis A , B , C , Wilson 's Disease , alpha1antitrypsin deficiency Known HIV positive Symptomatic angina pectoris cardiac insufficiency define NYHA classification Functional Class III IV Major vascular event within 6 month screen ( e.g . MI , stroke ) Active cancer within 5 year prior screen Current systemic disease , include type 1 2 diabetes Enrolled another research study within 1 month prior screen Implanted paramagnetic material ( subject need fill Yale Magnetic Resonance Center safety checklist ) Anemia ( HCT &lt; 35 % )</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>steatosis</keyword>
	<keyword>fatty liver</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>fatty liver ( steatosis )</keyword>
</DOC>